Phenylketonuria

What is phenylketonuria?

Phenylketonuria, often shortened to PKU, is a rare inherited condition in which the body cannot properly break down an amino acid called phenylalanine. Amino acids are the small building blocks of protein, and phenylalanine is found in almost all protein-containing foods, including meat, fish, eggs, dairy products, nuts, and beans. In people with phenylketonuria, an enzyme called phenylalanine hydroxylase is missing or does not work well. An enzyme is a protein that helps chemical reactions happen in the body. Without enough working enzyme, phenylalanine builds up in the blood and can reach levels that are harmful to the brain, especially in babies and young children whose brains are still developing.

Phenylketonuria is present from birth and lasts for life. It affects both boys and girls, and it occurs in all parts of the world, although how common it is varies between populations. Because early treatment can prevent most of the serious problems linked to the condition, many countries screen every newborn for phenylketonuria in the first days of life. When the condition is found early and managed with a special diet and, in some cases, medication, most people with phenylketonuria can grow, learn, and live full lives.

Understanding what is phenylketonuria, how it is inherited, and how it is treated helps families take an active role in care. This page explains phenylketonuria symptoms, causes, diagnosis, and the main treatment options in plain language.

Symptoms of phenylketonuria

Newborns with phenylketonuria usually look completely healthy at birth. This is one of the reasons newborn screening is so important: by the time phenylketonuria symptoms appear, some damage to the developing brain may already have occurred. Symptoms typically develop gradually over the first weeks and months of life if the condition is not treated.

Possible signs and symptoms of untreated phenylketonuria include:

• Developmental delay — the baby is slower than expected to reach milestones such as sitting, crawling, or talking.
• Intellectual disability — long-lasting problems with learning and thinking, which can become severe without treatment.
• Seizures — episodes of abnormal electrical activity in the brain that can cause jerking movements or loss of awareness.
• Behavioral and emotional problems — such as hyperactivity, irritability, or, in older children and adults, difficulty concentrating.
• A musty or “mousy” odor — of the breath, skin, or urine, caused by excess phenylalanine byproducts leaving the body.
• Lighter skin, hair, and eye color — than family members, because phenylalanine buildup interferes with the production of melanin, the pigment that colors skin and hair.
• Skin rashes — such as eczema, an itchy, inflamed skin condition.
• An unusually small head size — known as microcephaly, in severe untreated cases.
• Tremors or unusual movements — including jerky or repetitive movements of the arms and legs.

Phenylketonuria symptoms can differ depending on the type and severity of the condition. In classic phenylketonuria, the enzyme is almost completely absent, phenylalanine levels rise very high, and untreated children are at greatest risk of severe brain injury. In milder forms, sometimes called mild PKU or mild hyperphenylalaninemia (a term meaning mildly raised phenylalanine in the blood), the enzyme retains some activity. People with these milder forms may have fewer or less severe symptoms, and some may need less strict dietary treatment, although this is decided by a specialist based on blood test results.

Importantly, people who are diagnosed at birth and treated consistently often have few or no obvious symptoms. However, even in treated individuals, phenylalanine levels that drift too high over time may be linked to problems such as difficulty concentrating, mood changes, or slower processing of information. This is why lifelong monitoring is generally recommended.

Causes and risk factors

Phenylketonuria causes are genetic. The condition results from changes, called mutations or variants, in the gene that carries the instructions for making the phenylalanine hydroxylase enzyme. This gene is known as the PAH gene. When the gene is altered, the enzyme it produces is missing, reduced, or faulty, and the body cannot convert phenylalanine into another amino acid called tyrosine as it normally would. As a result, phenylalanine accumulates in the blood and tissues.

Phenylketonuria is inherited in an autosomal recessive pattern. This means a child must inherit two altered copies of the gene — one from each parent — to develop the condition. Parents who each carry one altered copy usually have no symptoms themselves and are called carriers. When both parents are carriers, each pregnancy has, on average, a one-in-four chance of resulting in a child with phenylketonuria.

Key risk factors include:

• Family history — having a parent, sibling, or other close relative with phenylketonuria or known carrier status increases the chance of the condition in a child.
• Both parents being carriers — often unknown until a child is diagnosed, since carriers are typically healthy.
• Certain ancestries — the condition is more common in some populations than in others, although it can occur in any family.

A related but separate concern is maternal PKU. If a woman with phenylketonuria has high phenylalanine levels during pregnancy, the excess phenylalanine can harm the developing baby, even if the baby does not have phenylketonuria itself. Possible effects include low birth weight, a small head, heart problems, and developmental delay. For this reason, doctors generally advise women with phenylketonuria to keep their phenylalanine levels tightly controlled before conception and throughout pregnancy, under close specialist supervision.

In a small number of people, high phenylalanine levels are caused not by a faulty PAH gene but by problems with a helper molecule called tetrahydrobiopterin, or BH4, which the enzyme needs to work. Doctors test for this possibility because it changes how the condition is managed.

Diagnosis

Phenylketonuria diagnosis usually begins with newborn screening. In many countries, a few drops of blood are taken from the baby’s heel, typically between 24 and 72 hours after birth, and placed on a special card. This is often called the heel-prick test or Guthrie test. The laboratory measures the level of phenylalanine in the blood. If the level is higher than expected, the result is flagged and the family is contacted for further testing.

Confirming the diagnosis generally involves:

• Repeat blood tests — measuring phenylalanine and tyrosine levels in the blood to confirm that phenylalanine is truly elevated and to gauge how severe the condition is.
• Genetic testing — analyzing the PAH gene to identify the specific variants responsible. This can help predict severity, guide treatment decisions, and inform family planning.
• Tests to rule out BH4 deficiency — additional blood or urine tests, and sometimes a supervised trial dose of BH4, to check whether the problem lies with the enzyme itself or with its helper molecule, since the treatment differs.

Imaging tests such as brain scans are not needed to diagnose phenylketonuria, although a doctor may occasionally order them if there are neurological symptoms that need further evaluation. In older children or adults who were never screened at birth — for example, those born in places without screening programs — doctors may test for phenylketonuria when there is unexplained developmental delay, intellectual disability, seizures, or the characteristic musty odor.

Once phenylketonuria is confirmed, care is usually coordinated by specialists in inherited metabolic diseases, often working within pediatric departments alongside dietitians experienced in metabolic nutrition. Regular blood tests to monitor phenylalanine levels become a routine part of life, with testing typically more frequent in infancy and early childhood, when the brain is most vulnerable.

Treatment options for phenylketonuria

There is currently no cure for phenylketonuria, but effective treatment exists, and starting it early — ideally within the first weeks of life — makes a major difference. The goal of phenylketonuria treatment is to keep blood phenylalanine levels within a safe target range while making sure the person still gets enough protein and nutrients to grow and stay healthy. Watchful waiting is not appropriate for confirmed classic phenylketonuria, because untreated high phenylalanine levels can cause permanent brain injury; however, people with very mild elevations may only need regular monitoring, as judged by their specialist.

The main components of treatment are:

• A low-phenylalanine diet — the cornerstone of treatment. This means strictly limiting high-protein foods such as meat, fish, eggs, cheese, milk, nuts, and regular bread and pasta. Instead, people with phenylketonuria eat measured amounts of low-protein foods, special low-protein products, and fruits and vegetables as advised by their dietitian.
• Medical formula (protein substitute) — because natural protein is restricted, people with phenylketonuria take a special formula that supplies all the other amino acids, vitamins, and minerals the body needs, without phenylalanine. Infants receive special phenylalanine-free infant formula, often combined with carefully measured amounts of breast milk or regular formula under specialist guidance.
• Avoiding aspartame — aspartame is an artificial sweetener found in many diet drinks, sugar-free products, and some medications. It is broken down into phenylalanine in the body, so people with phenylketonuria are advised to avoid it. Product labels in many countries carry a warning for this reason.
• Medication — some people respond to a medication called sapropterin, a synthetic form of the BH4 helper molecule, which can boost the activity of the remaining enzyme in those who have some enzyme function. In certain adults with phenylketonuria that is hard to control, doctors may consider an injectable enzyme-substitution therapy known as pegvaliase, which breaks down phenylalanine through a different pathway. Not everyone is a candidate for these medications, and they are prescribed and monitored by specialists.
• Regular blood monitoring — frequent blood tests, often done at home on filter-paper cards and sent to the laboratory, allow the care team to adjust the diet and treatment as the person grows and their needs change.

Surgery is not a treatment for phenylketonuria itself. Research into newer approaches, including gene-based therapies, is ongoing, but these are not yet standard care, and families should rely on their metabolic team for up-to-date guidance.

Because phenylketonuria is diagnosed in infancy and requires careful, coordinated follow-up throughout childhood, care is commonly delivered through specialized pediatric services. At hospital groups such as Acibadem, children with metabolic conditions like phenylketonuria are typically followed within the pediatrics department, working together with dietitians and, where needed, genetic counselors — professionals who help families understand inherited conditions and their implications.

Most experts now recommend that treatment continue for life. In the past, some people were allowed to relax the diet in later childhood, but evidence suggests that keeping phenylalanine levels controlled into adulthood supports better concentration, mood, and overall brain function. Any change to the diet or medication plan should always be discussed with the metabolic team first.

Living with phenylketonuria and outlook

The outlook for people with phenylketonuria depends largely on how early treatment starts and how consistently phenylalanine levels are kept in the target range. Babies who are diagnosed through newborn screening and treated from the first weeks of life generally develop normally and can attend regular school, work, and have families of their own. In contrast, when the condition goes untreated in early childhood, the resulting intellectual disability is usually permanent, although starting treatment later may still improve behavior and prevent further decline.

Day-to-day life with phenylketonuria involves ongoing attention to food. Families learn to count the phenylalanine or protein content of meals, prepare low-protein alternatives, and plan ahead for school, travel, and social events. This can feel demanding, especially during adolescence, when young people take over responsibility for their own diet. Support from dietitians, patient organizations, and other families with phenylketonuria often makes the routine easier to sustain.

Adults with phenylketonuria are encouraged to remain under specialist follow-up. Women who wish to become pregnant need particularly careful planning, because strict phenylalanine control before and during pregnancy protects the developing baby. With good preparation and monitoring, many women with phenylketonuria have healthy pregnancies.

It is honest to say that living with phenylketonuria requires lifelong effort, and that no treatment plan can guarantee a specific outcome. However, with early diagnosis, consistent treatment, and regular monitoring, most people with phenylketonuria today can expect a healthy life and a normal life expectancy.

Frequently asked questions

What is phenylketonuria in simple terms?

Phenylketonuria is an inherited condition in which the body cannot break down phenylalanine, a building block of protein found in most protein-rich foods. Without treatment, phenylalanine builds up in the blood and can damage the developing brain. It is present from birth, is usually detected by newborn screening, and is managed mainly with a special low-protein diet and medical formula.

Can phenylketonuria be cured or heal on its own?

No. Phenylketonuria is a lifelong genetic condition and does not go away on its own, and there is currently no cure. However, it can be managed very effectively. With early and consistent treatment, most people with phenylketonuria avoid the serious complications of the untreated condition. Research into newer therapies is ongoing, and your care team can explain which options apply to your situation.

How serious is phenylketonuria?

Untreated phenylketonuria is serious: persistently high phenylalanine levels in infancy and childhood can cause permanent intellectual disability, seizures, and behavioral problems. Treated phenylketonuria is a very different picture. When the diet and monitoring plan are followed from early life, most people develop normally. The seriousness of the condition therefore depends greatly on how early it is found and how well it is managed over time.

What are the first phenylketonuria symptoms in a baby?

Babies with phenylketonuria usually appear healthy at birth. If the condition is not detected and treated, early signs may include poor feeding, irritability, a musty odor of the skin or urine, skin rashes, and, over the following months, delays in reaching developmental milestones. Because symptoms appear only after phenylalanine has already started to build up, newborn screening remains the most reliable way to catch the condition early.

Do people with phenylketonuria have to follow the diet forever?

Current expert guidance in most countries recommends lifelong treatment. Keeping phenylalanine levels in the target range throughout adulthood appears to support better concentration, mood, and mental clarity, and it is essential for women before and during pregnancy. The strictness of the diet varies from person to person depending on the severity of the condition, so any adjustments should be made together with the metabolic team.

Can adults be diagnosed with phenylketonuria?

Yes, although it is uncommon in countries with newborn screening programs. Adults who were born before screening was introduced, or in regions without it, may be diagnosed later in life, sometimes during an evaluation for unexplained developmental or neurological problems. Blood tests measuring phenylalanine levels, followed by genetic testing, can confirm the diagnosis at any age, and treatment may still bring benefits even when started late.

If I have phenylketonuria, will my children have it too?

Not necessarily. A person with phenylketonuria passes one altered copy of the gene to each child. The child will only develop phenylketonuria if the other parent also passes on an altered copy, which happens when the other parent is a carrier or also has the condition. Genetic counseling can help couples understand their specific risk. Separately, women with phenylketonuria need strict phenylalanine control during pregnancy to protect the baby, regardless of whether the baby inherits the condition.

When to see a doctor

If your baby’s newborn screening result is flagged for phenylketonuria, follow up with your pediatric or metabolic team as soon as they contact you — early treatment matters most in the first weeks of life. For people already diagnosed with phenylketonuria, contact your care team promptly if blood phenylalanine results are running high, if the prescribed formula is not being tolerated, or before making any change to the diet or medications.

Seek medical attention urgently if you notice any of the following warning signs:

• Seizures — jerking movements, staring spells, or loss of consciousness in an infant or child.
• A baby who is unusually drowsy, floppy, or difficult to wake, or who is feeding very poorly.
• Persistent vomiting that prevents an infant from keeping down formula or feeds.
• Noticeable loss of previously gained skills — for example, a child who stops sitting, walking, or talking as they did before.
• A strong musty odor of the skin, breath, or urine in a baby who has not yet been evaluated.
• New tremors, stiffness, or unusual repetitive movements.
• An unplanned pregnancy in a woman with phenylketonuria — rapid specialist review is important to bring phenylalanine levels under control quickly.

Even outside of emergencies, regular follow-up visits and scheduled blood tests are an essential part of living safely with phenylketonuria. If you have concerns about your child’s development, feeding, or behavior at any point, discussing them with your doctor early is always reasonable.